Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...rmaceutical products, including product pricing, the regulatory environment and patent status, which together shape the national hepatitis response in different settings. It highlights key areas for action by ministries of health and other government decision-makers, pharmaceutical manufacturers and technical partners.
more
These recommendations for the education of mid-level rehabilitation workers are based on experiences in planning and implementing training programmes in nine countries. This information is useful in designing and developing training programmes specific to community-based rehabilitation
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
Introducing the cholera user-friendly app. As part of the effective implementation of the Ending Cholera: A Global Roadmap to 2030, the GTFCC developed a phone-based application containing technical information and practical documents to provide clear guidance and up to date information for early de...tection, monitoring and efficient response to cholera outbreaks. The application is designed for public health professionals from all sectors working in cholera control. The app is designed to be used offline to accommodate those working in the most remote areas.
more
These forms are intended only for clinicians and nurses taking care of patients with Ebola virus disease. They provide standardized information that needs to be collected by the clinicians at admission time, every day and at time of discharge.
These forms are intended only for clinicians and nurses taking care of patients with Ebola virus disease. They provide standardized information that needs to be collected by the clinicians at admission time, every day and at time of discharge.
This document includes the results of a rapid systematic review of current available literature. The information included in this review reflects the evidence as of the date posted in the document. In recognition of the fact that there are numerous ongoing clinical studies, PAHO will periodically up...date this review and corresponding recommendations as new evidence becomes available.
more
Four major objectives are set forth: more effective leadership and governance for mental health; the provision of comprehensive, integrated mental health and social care services in community-based settings; implementation of strategies for promotion and prevention; and strengthened information syst...ems, evidence and research.
more
This guide to local production of WHO-recommended handrub formulations is separated into two discrete but interrelated sections:
Part A provides a practical guide for use at the pharmacy bench during the actual preparation of the formulation. Users may want to display the material on the wall of ...the production unit.
Part B summarizes some essential background technical information and is taken from WHO Guidelines on Hand Hygiene in Health Care (2009). Within Part B the user has access to important safety and cost information and supplementary material relating to dispensers and distribution.
more
Guidance for health care workers.
Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.
This 2015 edition not only updates important changes published in the MEC fifth edition, but also includes several user-friendly features and additional supplemental information, in response to requests WHO has received from stakeholders and partners.
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
This summary outlines the burden of targeted diseases and program implementation outcomes in Rwanda. The control of neglected tropical diseases represents a major challenge to those providing healthcare services in the endemic countries. The purpose of this country profile is to provide public healt...h professionals with the most recently available epidemiological information on diseases for which a strategy and tools to implement large-scale preventive chemotherapy exist.
more
l Plan de Participación de Partes Interesadas (en adelante PPPI) se formula en cumplimiento de las directrices y requisitos que se expresan en el Estándar Ambiental y Social 10 “Participación de las partes interesadas y divulgación de la información” del Banco Mundial (en adelante EAS 10). ...Este estándar brinda los referentes para que, en los proyectos que financia el Banco Mundial, se constituyan tres (3) tipos de mecanismos que garanticen el involucramiento de las partes interesadas en los asuntos que les conciernen y son de su interés: de participación, de divulgación de información y de atención a quejas y reclamos.
more
10 July 2020
Guidance for authorities and event organizers planning mass gatherings during the current COVID-19 pandemic
The content of this Risk Assessment tool has been updated to reflect new WHO guidance and new evidence on both COVID-19 and mass gatherings, as well as feedback from end-users.
...
Additional improvements have been made to the way the information is organized and presented: the Decision Tree is now built into the tool and a new tab dedicated to Risk Communication has been added. The expanded tool now includes six tabs: 1. Instructions; 2. Decision Tree; 3. Risk Evaluation; 4. Risk Mitigation; 5. Decision Matrix; 6. Risk Communication.
more
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
The WHO website titled "Malaria" provides a comprehensive overview of malaria, a potentially fatal disease caused by Plasmodium parasites and primarily transmitted through mosquito bites in tropical countries. It offers information on symptoms, at-risk groups, preventive measures, and treatment opti...ons. The site also presents recent statistics: in 2023, an estimated 263 million malaria cases and 597,000 deaths occurred in 83 countries, with the African region being the most affected—accounting for 94% of cases and 95% of deaths. Children under the age of five made up approximately 76% of the deaths in this region.
more
The WHO website titled "Malaria" provides a comprehensive overview of malaria, a potentially fatal disease caused by Plasmodium parasites and primarily transmitted through mosquito bites in tropical countries. It offers information on symptoms, at-risk groups, preventive measures, and treatment opti...ons. The site also presents recent statistics: in 2023, an estimated 263 million malaria cases and 597,000 deaths occurred in 83 countries, with the African region being the most affected—accounting for 94% of cases and 95% of deaths. Children under the age of five made up approximately 76% of the deaths in this region.
more
The WHO website titled "Malaria" provides a comprehensive overview of malaria, a potentially fatal disease caused by Plasmodium parasites and primarily transmitted through mosquito bites in tropical countries. It offers information on symptoms, at-risk groups, preventive measures, and treatment opti...ons. The site also presents recent statistics: in 2023, an estimated 263 million malaria cases and 597,000 deaths occurred in 83 countries, with the African region being the most affected—accounting for 94% of cases and 95% of deaths. Children under the age of five made up approximately 76% of the deaths in this region.
more
El informe Indicadores básicos 2019: tendencias de la salud en las Américas comienza con un panorama demográfico de la Región que muestra los cambios que han ocurrido a lo largo de los últimos 25 años. Estos indicadores demográficos proporcionan un contexto útil para comprender mejor las car...acterísticas de la población y el efecto que tienen en la salud. Los gráficos están acompañados de breves descripciones en las que se destaca la información más importante.
more